Enhancing Exposure Therapy for PTSD: Virtual Reality and Imaginal Exposure with a Cognitive Enhancer
The purpose of this study was to treat symptoms of post-traumatic stress disorder (PTSD) resulting from exposure to the current Iraq and Afghanistan wars. Participants were randomly be assigned to receive traditional prolonged exposure therapy or prolonged exposure therapy combined with Virtual Reality. We were also examining the effects of using D-Cycloserine (DCS) in conjunction with treatment.
Behavioral and neuroanatomical manifestations of extinction learning in returning OIF/OEF veterans with mild traumatic brain injury
The purpose of this study was to learn about the effects that TBI has on extinction learning- a type of learning that has been identified as important in the development of anxiety disorders. We also wanted to better understand the effects that TBI has on functioning in general, and on mood and anxiety symptoms. This was done for the larger purpose of helping us to learn about the ways that our minds process stress.
D-cycloserine Enhanced Imaginal Exposure Therapy for Posttraumatic Stress Disorder (PTSD)
The purpose of this study is to treat symptoms of Posttraumatic stress disorder (PTSD) resulting from various traumas using traditional treatment combined with the use of D-Cycloserine (DCS).
World Trade Center 9/11 Virtual Reality Clinical Study
The purpose of this study is to treat symptoms of Posttraumatic stress disorder (PTSD) resulting from 9/11 using traditional treatment combined with the Virtual Reality Therapy program. We will also be examining the effects of using D-Cycloserine (DCS) in conjunction with the virtual reality treatment.
A POC Clinical Trial for PTSD with a First-in-Class Vasopressin 1a Receptor Antagonist
This study was a clinical trial which tested an experimental drug for the treatment of Post-Traumatic Stress Disorder (PTSD).
The population recruited were individuals who have served in the Iraq or Afghanistan wars and were experiencing any difficulties related to a mild or moderate traumatic brain injury (TBI) sustained during deployment.